Operator Welcome to Valion Bio, Inc.'s conference call to discuss first quarter 2026 financial results. This call has been prerecorded. The call is being webcast, and the replay will be available on the Investors section of the company's website for 90 days. Before we begin, please note that during today's call, management will make various forward-looking statements. Investors are cautioned that these forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results or outcomes to differ materially from those indicated in the forward-looking statements. Forward-looking statements include, without limitation, statements regarding the FDA's Animal Rule pathway and the development of Entolimod and Entolasta. The company's engagement with BARDA, NIAID, the Department of War and other U.S.…